Analyst Ranking
Bottom 10%
#4408 out of 4867 analysts
Average Return
-2.46%
Win Rate
45%45 out of 101
Risk vs Reward
Poor
Good

Yatin Suneja's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Reata Pharmaceuticals IncRETA
+376.00%$36.21$172.36
2022-10-19 -
2023-09-25
Strong Buy
Longboard Pharmaceuticals IncLBPH
+138.96%$25.10$59.98
2024-01-02 -
2024-11-29
Strong Buy
Prometheus Biosciences IncRXDX
+102.65%$18.85$38.20
2021-04-06 -
2022-04-05
Strong Buy
Larimar Therapeutics IncLRMR
+101.36%$3.69$7.43
2023-05-17 -
2024-05-16
Strong Buy
Eyepoint Pharmaceuticals IncEYPT
+93.15%$6.13$11.84
2023-05-18 -
2024-05-17
Strong Buy

Yatin Suneja's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cabaletta Bio IncCABA
3Strong Buy$23.00+1,696.88%Reiterates
a month ago
Zura Bio LtdZURA
2Strong Buy$15.00+979.14%Reiterates
a month ago
Inflarx NvIFRX
3Strong Buy$10.00+589.66%Maintains
a month ago
Larimar Therapeutics IncLRMR
4Strong Buy$26.00+987.87%Reiterates
a month ago
Adicet Bio IncACET
1Strong Buy$7.00+1,025.40%Reiterates
a month ago
Dianthus Therapeutics IncDNTH
1Strong Buy$84.00+286.21%Reiterates
2 months ago
Zenas Biopharma IncZBIO
2Strong Buy$45.00+301.79%Reiterates
2 months ago
Argenx SeARGX
7Strong Buy$1,100.00+74.74%Maintains
2 months ago
Neurocrine Biosciences IncNBIX
4Strong Buy$163.00+52.00%Maintains
3 months ago
Immunovant IncIMVT
4Strong Buy$44.00+189.09%Maintains
3 months ago
Surrozen IncSRZN
3Strong Buy$45.00+331.12%Upgrades
4 months ago
Acadia Pharmaceuticals IncACAD
6Hold$20.00+38.60%Downgrades
4 months ago
Anaptysbio IncANAB
7Strong Buy$36.00+69.97%Maintains
5 months ago
Spyre Therapeutics IncSYRE
1Strong Buy$65.00+332.76%Maintains
6 months ago
Vigil Neuroscience IncVIGL
2Strong Buy$16.00+733.33%Maintains
9 months ago
Praxis Precision Medicines IncPRAX
2Strong Buy$170.00+356.99%Maintains
9 months ago
Regeneron Pharmaceuticals IncREGN
5Strong Buy$1,300.00+128.51%Maintains
9 months ago
Alumis IncALMS
1Strong Buy$32.00+639.03%Initiates Coverage On
9 months ago
Q32 Bio IncQTTB
1Strong Buy$100.00+6,330.87%Initiates Coverage On
10 months ago
Abivax SaABVX
1Strong Buy$50.00N/AInitiates Coverage On
a year ago
Celldex Therapeutics IncCLDX
4Strong Buy$90.00N/AMaintains
a year ago
Axsome Therapeutics IncAXSM
7Strong Buy$125.00N/AMaintains
a year ago
Longboard Pharmaceuticals IncLBPH
3Strong Buy$32.00N/AMaintains
a year ago
Roivant Sciences LtdROIV
2Strong Buy$16.00N/AMaintains
a year ago
Moonlake ImmunotherapeuticsMLTX
3Strong Buy$77.00N/AMaintains
a year ago
Tourmaline Bio IncTRML
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Neumora Therapeutics IncNMRA
1Strong Buy$22.00N/AInitiates Coverage On
2 years ago
Xenon Pharmaceuticals IncXENE
2Strong Buy$49.00N/AReiterates
2 years ago
Eyepoint Pharmaceuticals IncEYPT
2Strong Buy$55.00N/AMaintains
2 years ago
Bioxcel Therapeutics IncBTAI
2Strong Buy$736.00N/AMaintains
2 years ago
Biogen IncBIIB
3Strong Buy$350.00N/AUpgrades
2 years ago
Prometheus Biosciences IncRXDX
3Hold$200.00N/ADowngrades
2 years ago
Rapt Therapeutics IncRAPT
2Strong Buy$48.00N/AMaintains
2 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$116.50N/ADowngrades
2 years ago
Sage Therapeutics IncSAGE
3Strong Buy$48.00N/AMaintains
2 years ago
Phathom Pharmaceuticals IncPHAT
2Strong Buy$30.00N/AMaintains
2 years ago
Reata Pharmaceuticals IncRETA
1Strong Buy$75.00N/AInitiates Coverage On
3 years ago
Relmada Therapeutics IncRLMD
3HoldN/AN/ADowngrades
3 years ago
Karuna Therapeutics IncKRTX
1Strong Buy$330.00N/AMaintains
3 years ago
Bausch & Lomb CorpBLCO
1Strong Buy$24.00N/AInitiates Coverage On
3 years ago
Climb Bio IncCLYM
2HoldN/AN/ADowngrades
3 years ago
Seelos Therapeutics IncSEELQ
1Strong Buy$30,720.00N/AInitiates Coverage On
4 years ago
Global Blood Therapeutics IncGBT
1Strong BuyN/AN/AInitiates Coverage On
6 years ago
Seagen IncSGEN
1Strong Buy$80.00N/AUpgrades
7 years ago
Verona Pharma PLCVRNA
1Strong Buy$26.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.